Literature DB >> 23052640

Saphenous vein aorto-coronary graft atherosclerosis in patients with chronic kidney disease: more plaque calcification and necrosis, but less vasoconstrictor potential.

Theodor Baars1, Petra Kleinbongard, Dirk Böse, Thomas Konorza, Stefan Möhlenkamp, Jörg Hippler, Raimund Erbel, Gerd Heusch.   

Abstract

Atherosclerotic coronary arteries are more calcified in patients with than without chronic kidney disease (CKD). We addressed the potential for coronary microvascular obstruction in patients with and without CKD during stenting for saphenous vein aorto-coronary graft (SVG) stenosis under protection with a distal occlusion/aspiration device. In patients with and without CKD (n = 20/20), SVG plaque composition was analyzed from virtual histology using intravascular ultrasound analysis before stent implantation. There was more dense calcium and more necrotic core in patients with than without CKD (14 ± 3 vs. 3 ± 1 % and 21 ± 3 vs. 12 ± 2 % of plaque volume, respectively). Coronary aspirate was retrieved during stent implantation and divided into particulate debris and plasma. Patients with CKD had more particulate debris and calcium release than patients without CKD. In contrast, the release of serotonin was less in patients with than without CKD (0.4 ± 0.1 vs. 1.2 ± 0.3 μmol/L), whereas that of catecholamines, endothelin, tissue factor, thromboxane, tumor necrosis factor α, and C reactive protein was not significantly different. Confirming the biochemical results, aspirate plasma from patients with CKD induced less vasoconstriction of rat mesenteric arteries than that from patients without CKD (with endothelium (+E), 26 ± 7 %; without endothelium (-E): 28 ± 7 % vs. +E, 68 ± 12 %; -E: 95 ± 16 % of maximum KCl-induced vasoconstriction). Graft atherosclerosis of patients with CKD is more degenerated and releases more particulate debris and calcium, but the aspirate has surprisingly less serotonin and vasoconstrictor potential.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052640     DOI: 10.1007/s00395-012-0303-3

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  6 in total

1.  Baseline atrial fibrillation is associated with contrast-induced nephropathy after cardiac catheterization in coronary artery disease: Systemic review and meta-analysis.

Authors:  Narut Prasitlumkum; Chanavuth Kanitsoraphan; Veraprapas Kittipibul; Pattara Rattanawong; Pakawat Chongsathidkiet; Wisit Cheungpasitporn
Journal:  Clin Cardiol       Date:  2018-11-26       Impact factor: 2.882

2.  Aspirate from human stented saphenous vein grafts induces epicardial coronary vasoconstriction and impairs perfusion and left ventricular function in rat bioassay hearts with pharmacologically induced endothelial dysfunction.

Authors:  Helmut R Lieder; Theodor Baars; Philipp Kahlert; Petra Kleinbongard
Journal:  Physiol Rep       Date:  2016-08

Review 3.  A fresh look at coronary microembolization.

Authors:  Petra Kleinbongard; Gerd Heusch
Journal:  Nat Rev Cardiol       Date:  2021-11-16       Impact factor: 49.421

Review 4.  Myeloid leukocytes' diverse effects on cardiovascular and systemic inflammation in chronic kidney disease.

Authors:  Alexander Hof; Simon Geißen; Kezia Singgih; Martin Mollenhauer; Holger Winkels; Thomas Benzing; Stephan Baldus; Friedrich Felix Hoyer
Journal:  Basic Res Cardiol       Date:  2022-07-27       Impact factor: 12.416

5.  Coronary aspirate TNFα reflects saphenous vein bypass graft restenosis risk in diabetic patients.

Authors:  Theodor Baars; Thomas Konorza; Philipp Kahlert; Stefan Möhlenkamp; Raimund Erbel; Gerd Heusch; Petra Kleinbongard
Journal:  Cardiovasc Diabetol       Date:  2013-01-10       Impact factor: 9.951

6.  Release of Intracoronary Microparticles during Stent Implantation into Stable Atherosclerotic Lesions under Protection with an Aspiration Device.

Authors:  Patrick Horn; Theodor Baars; Philipp Kahlert; Christian Heiss; Ralf Westenfeld; Malte Kelm; Raimund Erbel; Gerd Heusch; Petra Kleinbongard
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.